Gene · 5209
Papers3,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic significance and expression pattern of glucose related genes in breast cancer: A comprehensive computational biology approach. | Saudi J Biol Sci | 2024 | 38173442 | PubTator, text mining | PubMed |
| Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. | Transl Oncol | 2024 | 38042134 | PubTator, text mining | PubMed |
| Metabolism Shapes Immune Responses to Staphylococcus aureus. | J Innate Immun | 2024 | 38016430 | PubTator, text mining | PubMed |
| Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington's disease. | bioRxiv | 2024 | 37961108 | PubTator, text mining | PubMed |
| Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment. | Stem Cell Rev Rep | 2024 | 37922108 | PubTator, text mining | PubMed |
| AMPK signaling inhibits the differentiation of myofibroblasts: impact on age-related tissue fibrosis and degeneration. | Biogerontology | 2024 | 37917219 | PubTator, text mining | PubMed |
| PFKFB3 promotes endometriosis cell proliferation via enhancing the protein stability of β-catenin. | Mol Cell Endocrinol | 2024 | 37820851 | PubTator, text mining | PubMed |
| Integrating network pharmacology and bioinformatics to explore and experimentally verify the regulatory effect of Buyang Huanwu decoction on glycolysis and angiogenesis after cerebral infarction. | J Ethnopharmacol | 2024 | 37806535 | PubTator, text mining | PubMed |
| B7-H3 Regulates Glucose Metabolism in Neuroblastom via Stat3/c-Met Pathway. | Appl Biochem Biotechnol | 2024 | 37405686 | PubTator, text mining | PubMed |
| IL-37 inhibits glycolysis of lung adenocarcinoma by inhibiting the expression of PFKFB3. | Cell Mol Biol (Noisy-le-grand) | 2023 | 38279421 | PubTator, text mining | PubMed |
| Glycolysis: an emerging regulator of osteoarthritis. | Front Immunol | 2023 | 38264652 | PubTator, text mining | PubMed |
| Revving the engine: PKB/AKT as a key regulator of cellular glucose metabolism. | Front Physiol | 2023 | 38264327 | PubTator, text mining | PubMed |
| Specific changes in amino acid profiles in monocytes of patients with breast, lung, colorectal and ovarian cancers. | Front Immunol | 2023 | 38259478 | PubTator, text mining | PubMed |
| Metabolic Enzymes in Viral Infection and Host Innate Immunity. | Viruses | 2023 | 38257735 | PubTator, text mining | PubMed |
| Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung. | Int J Mol Sci | 2023 | 38203486 | PubTator, text mining | PubMed |
| Ferroptosis, Metabolic Rewiring, and Endometrial Cancer. | Int J Mol Sci | 2023 | 38203246 | PubTator, text mining | PubMed |
| The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors. | Molecules | 2023 | 38202657 | PubTator, text mining | PubMed |
| Hitting the Sweet Spot: How Glucose Metabolism Is Orchestrated in Space and Time by Phosphofructokinase-1. | Cancers (Basel) | 2023 | 38201444 | PubTator, text mining | PubMed |
| Commentary: PFKFB3 overexpression in monocytes of patients with colon but not rectal cancer programs pro-tumor macrophages and is indicative for higher risk of tumor relapse. | Front Immunol | 2023 | 38193086 | PubTator, text mining | PubMed |
| Metformin: update on mechanisms of action on liver diseases. | Front Nutr | 2023 | 38192642 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5209/papers?page=18